Relative uptake of low- and high-osmolality contrast media in CT of brain tumors.

The magnitude and time course of contrast enhancement in spontaneous canine brain tumors was determined for two contrast agents: meglumine iothalamate and sodium meglumine ioxaglate. Tumor enhancement during contrast infusion and at 5, 10, 15, 30, and 45 min was measured using quantitative computed tomography. Blood iodine was measured using x-ray fluorescence. Peak contrast enhancement occurred during the infusion, and the magnitude was the same for both agents. Per gram of iodine infused, blood iodine was 12.4% higher with ioxaglate than iothalamate. The monoionic dimer ioxaglate is as effective as iothalamate for enhancement of canine brain tumors.

[1]  J. Fike,et al.  Radiotherapy of brain tumors in dogs. , 1984, Journal of the American Veterinary Medical Association.

[2]  M. Sage.  Review: Kinetics of Water-Soluble Contrast Media in the Central Nervous System , 1983 .

[3]  P. Dean,et al.  Contrast enhancement pharmacokinetics of six ionic and nonionic contrast media. , 1983, Investigative radiology.

[4]  E. Frenkel,et al.  Osmotic blood-brain barrier modification: clinical documentation by enhanced CT scanning and/or radionuclide brain scanning. , 1983, AJR. American journal of roentgenology.

[5]  D. A. Yates,et al.  A comparative trial of sodium meglumine ioxaglate (Hexabrix) and iopamidol (Niopam) for cerebral angiography. , 1982, The British journal of radiology.

[6]  J. Fike,et al.  Radiation effects in the canine brain evaluated by quantitative computed tomography. , 1982, Radiology.

[7]  J. Fike,et al.  Quantitative Evaluation of the Canine Brain Using Computed Tomography , 1982, Journal of computer assisted tomography.

[8]  L. Hedlund,et al.  Radiographic quantitation of reversible blood-brain barrier disruption in vivo. , 1982, Radiology.

[9]  R. Grainger.  Intravascular contrast media--the past, the present and the future. Mackenzie Davidson Memorial Lecture, April 1981. , 1982, The British journal of radiology.

[10]  J. Fike,et al.  COMPUTED TOMOGRAPHY OF BRAIN TUMORS IN THE CAUDAL FOSSA OF THE DOG , 1981 .

[11]  E. Frenkel,et al.  Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption. , 1981, Annals of internal medicine.

[12]  J. Fike,et al.  Computerized tomography of brain tumors of the rostral and middle fossas in the dog. , 1981, American journal of veterinary research.

[13]  R. Grainger.  Osmolality of intravascular radiological contrast media. , 1980, The British journal of radiology.

[14]  J. Lautrou,et al.  Pharmacokinetics of Contrast Media: Experimental Results in Dog and Man with CT Implications , 1980, Journal of computer assisted tomography.

[15]  R. Grainger.  A clinical trial of a new low osmolality contrast medium. Sodium and meglumine ioxaglate (Hexabrix) compared with meglumine iothalamate (Conray) for carotid arteriography. , 1979, The British journal of radiology.

[16]  D C Price,et al.  An automated fluorescent excitation analysis system for medical applications. , 1976, Investigative radiology.